USCDI Export for the Public
| Classification Level Sort descending | Data Class | Data Class Description | Data Element | Data Element Description | Applicable Standards | Submitter Name | Submitter Organization | Submission Date |
|---|---|---|---|---|---|---|---|---|
| Level 0 | Diagnostic Imaging | Tests that result in visual images requiring interpretation by a credentialed professional. |
Imaging Study - Content | Representation of the content produced in a DICOM imaging study. A study comprises a set of series, each of which includes a set of Service-Object Pair Instances (SOP Instances - images or other data) acquired or produced in a common context. A series is of only one modality (e.g. X-ray, CT, MR, ultrasound), but a study may have multiple series of different modalities. |
DICOM |
Deanne Kasim | Change Healthcare | |
| Level 0 | Cancer Care | Surgical Procedure As Part of Treatment | Was a of surgery used as part of treatment for this diagnosis (e.g., Yes, No, Indeterminant)? |
American Joint Committee on Cancer e.g. AJCC8 |
Charles Mayo, PhD | University of Michigan | ||
| Level 0 | Cancer Care | Systemic Therapy As Part of Treatment | Was a of systemic therapy used as part of treatment for this diagnosis? |
American Joint Committee on Cancer e.g. AJCC8 |
Charles Mayo, PhD | University of Michigan | ||
| Level 0 | Cancer Care | Radiation Therapy As Part of Treatment | Was a of radiation therapy used as part of treatment for this diagnosis ? This is important minimal set information needed for coordinated care and understanding outcomes for public health policy |
American Joint Committee on Cancer e.g. AJCC8 |
Charles Mayo, PhD | University of Michigan | ||
| Level 0 | Clinical Notes | Narrative patient data relevant to the context identified by note types.
|
Physical Exam | Narrative clinical assessment of the Physical Exam results. |
Please see suggestions from attached Excel document |
Melissa Ayres | SSA | |
| Level 0 | Clinical Notes | Narrative patient data relevant to the context identified by note types.
|
Genetic Testing | Narrative clinical assessment of the Genetic Testing results. |
Please see suggestions from attached Excel document |
Melissa Ayres | SSA | |
| Level 0 | Health Status Assessments | Assessments of a health-related matter of interest, importance, or worry to a patient, patient’s authorized representative, or patient’s healthcare provider that could identify a need, problem, or condition. |
Mental Status Evaluation | Narrative clinical assessment of the Mental Status Evaluation. |
Please see suggestions from attached Excel document |
Melissa Ayres | SSA | |
| Level 0 | Cancer Care | Cancer Treatment Site of Recurrence | If there is a recurrence, then list sites of recurrence . The AAPM Operational Ontology for Radiation Oncology ( https://aapmbdsc.azurewebsites.net) noted a Delphi process to identify standard values recommended for classification. These were Primary- None Primary - Prostate Primary - Seminal Vesicles Nodal-None Nodal-Pelvic Nodal-Aortic Nodal-Distant Distant-None Distant- CHAARTED-Low Volume Distant- CHAARTED-High Volume Metastatic-Bone Metastatic-Viscera In OORO for each instance record of a Cancer Patient Treatment Outcome, multiple values of Evaluation Site of Recurrence can be selected e.g. Primary- None,Nodal-Distant |
Charles Mayo | University of Michigan | |||
| Level 0 | Cancer Care | Cancer Treatment Evaluation Basis of Disease Status | What measures were used in the determination of the disease status. Physical exam PSA Plain film radiographs Bone scan Magnetic Resonance Imaging Computed Tomograph Biochemical marker (PSA) PET-CT (PSMA) PET-CT (F-18 fluciclovine) PET-CT (C-11 choline) In OORO for each instance record of a Cancer Patient Treatment Outcome, multiple values of Evaluation Basis of Disease Status can be selected e.g. PSA, MRI |
Charles Mayo | University of Michigan | |||
| Level 0 | Cancer Care | Radiation Therapy Dose Objective Value | Desired value for the specified Dose Objective |
Elizabeth Covington | University of Michigan | |||
| Level 0 | Cancer Care | Radiation Therapy Dose Objective Condition | Desired relationship of the Dose Objective to the Value Standard Values (List): = < <= > >= ALARA |
Elizabeth Covington | University of Michigan | |||
| Level 0 | Cancer Care | Radiation Therapy Dose Objective | TG-263 (https://www.aapm.org/pubs/reports/RPT_263.pdf) name of DVH metric for the objective |
Elizabeth Covington | University of Michigan | |||
| Level 0 | Cancer Care | Radiation Therapy Course Number Of Sessions in Course | Total number of sessions in the treatment course. A session is the period between when the patient enters the treatment room and when they leave it. |
Elizabeth Covington | University of Michigan | |||
| Level 0 | Cancer Care | Radiation Therapy Course Target Dose Volume | Radiation dose delivered to the target volume in fulfilling the prescription (e.g. 7200 cGy). |
Elizabeth Covington | University of Michigan | |||
| Level 0 | Cancer Care | Radiation Therapy Course Target Dose Volume | Name of target volume structure for radiation therapy (e.g. Prostate). |
Elizabeth Covington | University of Michigan | |||
| Level 0 | Cancer Care | Radiation Therapy Course Target Dose Volume | Identify targets and overall doses treated with the radiation therapy course. This supports systematic reporting what was done for treatment summaries. For example it enables identifying that the prostate received a dose of 7200 cGy. Where the prescription reflects intent, this element reflects what was delivered. |
Elizabeth Covington | University of Michigan | |||
| Level 0 | Cancer Care | Radiation Therapy Course - Involves Reirradiation | Does the radiation field for the current course overlap with radiation fields from prior courses of therapy? |
Elizabeth Covington | University of Michigan | |||
| Level 0 | Cancer Care | Pathology Molecular Test Name | Name of the molecular pathology test used as part of diagnosis and staging. There are a wide range of tests. In the case of prostate cancer values include: |
American Joint Committee on Cancer e.g. AJCC8 |
Charles Mayo, PhD | University of Michigan | ||
| Level 0 | Cancer Care | Provider Reported Toxicity Measure | For each Cancer Patient - Provider Reported Toxicity record the Toxicity Measure specifies what value is measured. For example if CTCAE v5.0 (https://ctep.cancer.gov/protocoldevelopment/electronic_applications/doc…) is used then the Toxicity Measure would correspond to CTCAE Term (e.g. Dry Mouth, or Dry Mouth) The AAPM Operational Ontology for Radiation Oncology ( https://aapmbdsc.azurewebsites.net) identified this as a high priority element supporting patient care, outcomes research and public policy |
Common Terminology Criteria for Adverse Events |
Charles Mayo | University of Michigan | ||
| Level 0 | Cancer Care | Radiation Therapy Course Target Dose Unit | Unit corresponding to numerical value of radiation dose (e.g. cGy) |
Elizabeth Covington | University of Michigan |
